135 related articles for article (PubMed ID: 6440414)
1. Detection of proteases of Pseudomonas aeruginosa in immune complexes isolated from sputum of cystic fibrosis patients.
Döring G; Buhl V; Høiby N; Schiøtz PO; Botzenhart K
Acta Pathol Microbiol Immunol Scand C; 1984 Oct; 92(5):307-12. PubMed ID: 6440414
[TBL] [Abstract][Full Text] [Related]
2. Proteases of Pseudomonas aeruginosa in patients with cystic fibrosis.
Döring G; Obernesser HJ; Botzenhart K; Flehmig B; Høiby N; Hofmann A
J Infect Dis; 1983 Apr; 147(4):744-50. PubMed ID: 6404993
[TBL] [Abstract][Full Text] [Related]
3. Role of Pseudomonas aeruginosa exoenzymes in lung infections of patients with cystic fibrosis.
Döring G; Goldstein W; Röll A; Schiøtz PO; Høiby N; Botzenhart K
Infect Immun; 1985 Sep; 49(3):557-62. PubMed ID: 3928491
[TBL] [Abstract][Full Text] [Related]
4. Lipopolysaccharide is present in immune complexes isolated from sputum in patients with cystic fibrosis and chronic Pseudomonas aeruginosa lung infection.
Kronborg G; Shand GH; Fomsgaard A; Høiby N
APMIS; 1992 Feb; 100(2):175-80. PubMed ID: 1554493
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic value of serum antibodies in early Pseudomonas aeruginosa infection in cystic fibrosis patients.
Ratjen F; Walter H; Haug M; Meisner C; Grasemann H; Döring G
Pediatr Pulmonol; 2007 Mar; 42(3):249-55. PubMed ID: 17243185
[TBL] [Abstract][Full Text] [Related]
6. Antibodies to proteases and exotoxin A of Pseudomonas aeruginosa in patients with cystic fibrosis: Demonstration by radioimmunoassay.
Klinger JD; Straus DC; Hilton CB; Bass JA
J Infect Dis; 1978 Jul; 138(1):49-8. PubMed ID: 98596
[TBL] [Abstract][Full Text] [Related]
7. Antibody response against Pseudomonas aeruginosa and its relationship with immune mediators in the upper and lower airways of cystic fibrosis patients.
Mauch RM; Hentschel J; Aanaes K; Barucha A; Nolasco da Silva MT; Levy CE; Høiby N; Mainz JG
Pediatr Pulmonol; 2020 Apr; 55(4):959-967. PubMed ID: 32022432
[TBL] [Abstract][Full Text] [Related]
8. Distribution of antibodies to selected antigens of Pseudomonas aeruginosa in children and young adults with cystic fibrosis.
Gaweł J; Pogorzelski A; Działek-Smętek E; Sochań B; Ligarska R; Lącka M; Mazurek H
Pneumonol Alergol Pol; 2014; 82(4):336-41. PubMed ID: 24964236
[TBL] [Abstract][Full Text] [Related]
9. Autoantibodies in serum and sputum from patients with cystic fibrosis.
Schiøtz PO; Egeskjold EM; Høiby N; Permin H
Acta Pathol Microbiol Scand C; 1979 Oct; 87(5):319-24. PubMed ID: 117671
[TBL] [Abstract][Full Text] [Related]
10. Epithelial cell damage is induced by neutrophil-derived, not pseudomonas-derived, proteases in cystic fibrosis sputum.
Venaille TJ; Ryan G; Robinson BW
Respir Med; 1998 Feb; 92(2):233-40. PubMed ID: 9616518
[TBL] [Abstract][Full Text] [Related]
11. Lipopolysaccharide (LPS), LPS-immune complexes and cytokines as inducers of pulmonary inflammation in patients with cystic fibrosis and chronic Pseudomonas aeruginosa lung infection.
Kronborg G
APMIS Suppl; 1995; 50():1-30. PubMed ID: 7756034
[TBL] [Abstract][Full Text] [Related]
12. Immune complexes in the sputum of patients with cystic fibrosis suffering from chronic Pseudomonas aeruginosa lung infection.
Schiøtz PO; Nielsen H; Høiby N; Glikmann G; Svehag SE
Acta Pathol Microbiol Scand C; 1978 Feb; 86(1):37-40. PubMed ID: 707104
[TBL] [Abstract][Full Text] [Related]
13. Prognostic implications of circulating immune complexes and Pseudomonas aeruginosa-specific antibodies in cystic fibrosis.
Dasgupta MK; Lam J; Döring G; Harley FL; Zuberbuhler P; Lam K; Reichert A; Costerton JW; Dossetor JB
J Clin Lab Immunol; 1987 May; 23(1):25-30. PubMed ID: 3112403
[TBL] [Abstract][Full Text] [Related]
14. Pseudomonas-infected cystic fibrosis patient sputum inhibits the bactericidal activity of normal human serum.
Schiller NL; Millard RL
Pediatr Res; 1983 Sep; 17(9):747-52. PubMed ID: 6413945
[TBL] [Abstract][Full Text] [Related]
15. Elastase from polymorphonuclear leucocytes: a regulatory enzyme in immune complex disease.
Döring G; Goldstein W; Botzenhart K; Kharazmi A; Schiøtz PO; Høiby N; Dasgupta M
Clin Exp Immunol; 1986 Jun; 64(3):597-605. PubMed ID: 2947759
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal study of immune response to Pseudomonas aeruginosa antigens in cystic fibrosis.
Döring G; Høiby N
Infect Immun; 1983 Oct; 42(1):197-201. PubMed ID: 6413411
[TBL] [Abstract][Full Text] [Related]
17. The role of bacterial proteases in the pathogenesis of cystic fibrosis.
Suter S
Am J Respir Crit Care Med; 1994 Dec; 150(6 Pt 2):S118-22. PubMed ID: 7952646
[TBL] [Abstract][Full Text] [Related]
18. EPI-hNE4, a proteolysis-resistant inhibitor of human neutrophil elastase and potential anti-inflammatory drug for treating cystic fibrosis.
Attucci S; Gauthier A; Korkmaz B; Delépine P; Martino MF; Saudubray F; Diot P; Gauthier F
J Pharmacol Exp Ther; 2006 Aug; 318(2):803-9. PubMed ID: 16627747
[TBL] [Abstract][Full Text] [Related]
19. IgG antibodies in early Pseudomonas aeruginosa infection in cystic fibrosis.
Cordon SM; Elborn JS; Rayner RJ; Hiller EJ; Shale DJ
Arch Dis Child; 1992 Jun; 67(6):737-40. PubMed ID: 1626995
[TBL] [Abstract][Full Text] [Related]
20. Immune complexes from immunized mice and infected cystic fibrosis patients mediate murine and human T cell killing of hybridomas producing protective, opsonic antibody to Pseudomonas aeruginosa.
Pier GB; Takeda S; Grout M; Markham RB
J Clin Invest; 1993 Mar; 91(3):1079-87. PubMed ID: 8450038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
